Centre warns against Remdesivir use in patients not on oxygen
The Centre on Friday said Remdesivir drug should only be used in patients with 'moderate to severe' COVID-19 and those with no renal or hepatic dysfunction within 10 days of the onset of any symptom. It also warned against use of the drug in patients who are not on oxygen support or in home settings.
According to the clinical guidance issued by the Union health ministry for management of the infection in adult patients, Remdesivir has been asked to be "used in patients with moderate to severe COVID-19 and those with no renal or hepatic dysfunction within 10 days of onset of any symptom".
For more details, check out the full story on the link below:
Centre Warns Against Remdesivir Use In Patients Not On Oxygen Support
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd